| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10897294 | Cancer Epidemiology | 2015 | 7 Pages |
Abstract
In this sample, ALK+ NSCLC patients were racially diverse with mixed smoking history. One in five patients were not tested before first-line therapy. Oncologists reported being more likely to consider ALK testing for patients with particular smoking and race characteristics.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Annie Guérin, Medha Sasane, Jie Zhang, Alexander R. Macalalad, Philip Galebach, John Jarvis, Andrew Kageleiry, Kenneth Culver, Eric Q. Wu, Heather Wakelee,